LYMPHOMA PATIENTS WITH HIGH-RISK OF CENTRAL NERVOUS SYSTEM RELAPSE

Clinical trials for LYMPHOMA PATIENTS WITH HIGH-RISK OF CENTRAL NERVOUS SYSTEM RELAPSE explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA PATIENTS WITH HIGH-RISK OF CENTRAL NERVOUS SYSTEM RELAPSE trials appear

Sign up with your email to follow new studies for LYMPHOMA PATIENTS WITH HIGH-RISK OF CENTRAL NERVOUS SYSTEM RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New transplant strategy aims to stop lymphoma from spreading to the brain

Disease control Recruiting now

This study is testing a modified chemotherapy regimen given before a patient's own stem cells are transplanted back into them. It is for people with non-Hodgkin lymphoma who are at high risk of the cancer spreading to their brain or spinal cord. The goal is to see if this approac…

Matched conditions: LYMPHOMA PATIENTS WITH HIGH-RISK OF CENTRAL NERVOUS SYSTEM RELAPSE

Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

LYMPHOMA PATIENTS WITH HIGH-RISK OF CENTRAL NERVOUS SYSTEM RELAPSE

Get alerted when new LYMPHOMA PATIENTS WITH HIGH-RISK OF CENTRAL NERVOUS SYSTEM RELAPSE trials appear

New transplant strategy aims to stop lymphoma from spreading to the brain